Currently, two FDA-approved GLP-1 receptor agonists are directly derived from the Gila monster venom peptide exendin-4: exenatide (Byetta) and exenatide extended-release (Bydureon, Bydureon BCise)
They will assess your medical history, your current response to the medications, potential drug interactions, and side effects, and create a personalized plan based on your bodys response
When a plateau occurs, your clinician evaluates whether a dose increase is appropriate or whether metabolic rest, dietary refinement, or activity enhancement would serve you better
There are different forms of glutathione used in supplementation: Reduced Glutathione (GSH): The most biologically active and commonly used in IV therapy
Special focus on GLP-1 products